Data as of Nov 26
| +0.44 / +0.92%|
The 28 analysts offering 12-month price forecasts for Sanofi have a median target of 50.42, with a high estimate of 59.00 and a low estimate of 45.57. The median estimate represents a +4.84% increase from the last price of 48.09.
The current consensus among 30 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.